For Pacific GeneTech (PGT), they aim to improve life with biotechnology. Recognizing the interconnection between people, animals, plants and their shared environment in achieving optimal health outcomes, this innovative company takes a One Health approach in tackling the important issues facing society.
PGT is a biologics company that develops and commercializes next generation vaccines and adjuvant delivery systems to prevent zoonotic and other diseases including Salmonella, E. coli and other GI tract bacteria, apicomplexan parasites, and viruses such as influenza and African Swine Fever. They are the latest company to join Emergence: Canada’s Bioscience Business Incubator alongside a cohort of innovative companies currently in the program.
PGT was founded in 2009 in the United States to take discovery vaccine research into commercial development. Today, they have a substantial and growing international footprint, and have expanded the platform and technology through support from partners around the globe. PGT vaccines provide cross protection, eliminating need for multiple vaccines and addressing the problem of mutation.
“Canada is an important centre for vaccine research in both the animal and human fields, and we are very pleased to be a part of the Emergence program which will enable us to tap into important new industry and scientific resources,” said Tim Collard, CEO, PGT.
Emergence is a business incubator dedicated to assisting start-ups and growth-stage bioscience companies in efficiently bringing their products and services to market. As part of the Emergence program, Pacific GeneTech will have access to business incubation services including:
Mentorship and advisory services: Emergence companies receive long-term expert advice from mentors, selected for their relevant experience, as well as services to fill in specific gaps in the company’s critical path.
Team Mentorship Program: The Critical Path Team Mentorship Program matches companies with skilled volunteer mentors to provide practical, day-to-day professional advice and business coaching.
Access to networks and resources: Emergence companies have access to networks including funding agencies, regulatory bodies, future talent, public organizations, service providers, investors, potential partners, and bioscience cluster companies.